Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
11.05.2017 21:47:00

H1 Keratoconjunctivitis sicca Pipeline 2017 Overview, Market Companies and Drug Profile Development Published at ReportsnReports.com

PUNE, India, May 11, 2017 /PRNewswire-iReach/ -- Latest report Keratoconjunctivitis sicca Pipeline Market Review, H1 2017 is added to ReportsnReports.com store. The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Browse the 116 Tables and 11 Figures, 40 Company Profiles, Spread across 187 Pages Report Available at http://www.reportsnreports.com/reports/992875-keratoconjunctivitis-sicca-dry-eye-pipeline-review-h1-2017.html

Keratoconjunctivitis sicca Companies:  Aldeyra Therapeutics Inc, Allergan Plc, Ascendia Pharmaceuticals LLC , BioLineRx Ltd , Cambium Medical Technologies LLC , Chong Kun Dang Pharmaceutical Corp , Dompe Farmaceutici SpA , Elasmogen Ltd , HanAll Biopharma Co Ltd, Herantis Pharma Plc , Huons Co Ltd , InSite Vision Inc , Kala Pharmaceuticals Inc , KPI Therapeutics Inc , Kukje Pharmaceutical Industry Co Ltd , Laboratoires Thea SA , Lipicard Technologies Ltd , Merck & Co Inc , Mimetogen Pharmaceuticals Inc , Mitotech SA , Nanomerics Ltd , Nemus Bioscience Inc, Neuroptis Biotech , Novaliq GmbH , Ocular Therapeutix Inc , Oculis ehf , OncoNOx ApS, Otsuka Holdings Co Ltd , Parion Sciences Inc , Quorum Innovations LLC , RegeneRx Biopharmaceuticals Inc , Samjin Pharmaceutical Co Ltd , Santen Pharmaceutical Co Ltd , Seikagaku Corp , Shire Plc , Sun Pharmaceutical Industries Ltd , TearSolutions LLC , TopiVert Ltd , Vanda Pharmaceuticals Inc 47, Xigen SA 47.

Keratoconjunctivitis sicca (Dry Eye) - Drug Profiles : ADX-102, ADX-103, AGN-195263, AGN-223575, AGN-232411, AL-41A1,

Androgen Tears - Drug Profile : AVA-3486, AVX-012, AX-1606, BL-1230, BRM-421

Order a Copy of Report athttp://www.reportsnreports.com/purchase.aspx?name=992875

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS) or keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Symptoms include eye fatigue, sensitivity to light, eye redness and stringy mucus in or around eyes. Risk factors include age, having laser eye surgery and taking medications that can cause dry eyes.

Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Discount Available at http://www.reportsnreports.com/contacts/discount.aspx?name=992875

List of Figures

Number of Products under Development for Keratoconjunctivitis sicca (Dry Eye), H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

Related New Reports:

Uveitis - Pipeline Review, H1 2017

Retinopathy Of Prematurity - Pipeline Review, H1 2017

Glaucoma - Pipeline Review, H1 2017

Explore Other Reports on Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at sales@reportsandreports.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.
 

Media Contact:Ritesh Tiwari, ReportsnReports, + 1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE ReportsnReports

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!